BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20357094)

  • 21. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
    Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
    J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restriction of HIV-1 by rhesus TRIM5α is governed by alpha helices in the Linker2 region.
    Sastri J; Johnsen L; Smolin N; Imam S; Mukherjee S; Lukic Z; Brandariz-Nuñez A; Robia SL; Diaz-Griffero F; Wiethoff C; Campbell EM
    J Virol; 2014 Aug; 88(16):8911-23. PubMed ID: 24872590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner.
    Ohainle M; Kim K; Komurlu Keceli S; Felton A; Campbell E; Luban J; Emerman M
    PLoS Pathog; 2020 Apr; 16(4):e1008507. PubMed ID: 32282853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
    Diaz-Griffero F; Kar A; Lee M; Stremlau M; Poeschla E; Sodroski J
    Virology; 2007 Dec; 369(2):400-10. PubMed ID: 17920096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
    Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
    J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction.
    Yang Y; Brandariz-Nuñez A; Fricke T; Ivanov DN; Sarnak Z; Diaz-Griffero F
    Virology; 2014 Jan; 448():217-28. PubMed ID: 24314652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fates of retroviral core components during unrestricted and TRIM5-restricted infection.
    Kutluay SB; Perez-Caballero D; Bieniasz PD
    PLoS Pathog; 2013 Mar; 9(3):e1003214. PubMed ID: 23505372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races.
    Tenthorey JL; Young C; Sodeinde A; Emerman M; Malik HS
    Elife; 2020 Sep; 9():. PubMed ID: 32930662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
    Keckesova Z; Ylinen LM; Towers GJ
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10780-5. PubMed ID: 15249687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a genomic reservoir for new TRIM genes in primate genomes.
    Han K; Lou DI; Sawyer SL
    PLoS Genet; 2011 Dec; 7(12):e1002388. PubMed ID: 22144910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro.
    Black LR; Aiken C
    J Virol; 2010 Jul; 84(13):6564-9. PubMed ID: 20410272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
    Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
    PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.
    Carthagena L; Parise MC; Ringeard M; Chelbi-Alix MK; Hazan U; Nisole S
    Retrovirology; 2008 Jul; 5():59. PubMed ID: 18613956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat.
    McEwan WA; Schaller T; Ylinen LM; Hosie MJ; Towers GJ; Willett BJ
    J Virol; 2009 Aug; 83(16):8270-5. PubMed ID: 19494015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.
    Song B; Gold B; O'Huigin C; Javanbakht H; Li X; Stremlau M; Winkler C; Dean M; Sodroski J
    J Virol; 2005 May; 79(10):6111-21. PubMed ID: 15857996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
    Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
    Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From Capsids to Complexes: Expanding the Role of TRIM5α in the Restriction of Divergent RNA Viruses and Elements.
    Rose KM; Spada SJ; Broeckel R; McNally KL; Hirsch VM; Best SM; Bouamr F
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33801908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism.
    Soll SJ; Wilson SJ; Kutluay SB; Hatziioannou T; Bieniasz PD
    PLoS Pathog; 2013; 9(9):e1003667. PubMed ID: 24086139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Takeuchi H; Ikeda Y
    PLoS One; 2011 Jan; 6(1):e16121. PubMed ID: 21264255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.